Bret Jensen
Contributor since: 2010
Company: The Biotech Forum
The Only Play On Amarin
A Quick Investment Idea On uniQure
Ovid Therapeutics: A Full Investment Analysis
Immunic: A 'Deep Dive' On A Lottery Ticket
China: The Potential Bubble Of All Bubbles Should Be On Your Radar
The Play On Omeros
Assessing An Investment In Avadel Pharmaceuticals
Jazz Pharmaceuticals: Buy, Sell, Or Hold
The Play On MacroGenics
Heron Therapeutics: The Play Now
The Play On Tutor Perini
ANI Pharmaceuticals: Significantly Undervalued
The Current COVID-19 Investment Landscape
The Play On Esperion Therapeutics
Gates Industrial Corporation: An Investment Assessment
Akari Therapeutics: An Investment Assessment
Ally Financial: Still Some Meat On The Bone
The Rally Is Overdue For A Pause
Revisiting Marker Therapeutics
Housing Plays For The Coming Exodus Out Of Big Cities
Assessing Axovant Gene Therapies
A Big Monkey Wrench In Any Economic Rebound
Planning For A Rebound In Flexion Therapeutics
Taking A Gander At GenMark Diagnostics
Mulling Over Mersana Therapeutics
Seeing An Opportunity In Clovis Oncology
The Play On Aimmune Therapeutics
Seizing The Day On Sorrento Therapeutics
Omeros: Some Concerns Remain... As Do Opportunities
Paratek Plods Along
Kala Pharmaceuticals: A Post Q1 Assessment
TPI Composites: Maintaining Growth Despite COVID-19